Samantha Steele
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
16
Citations
51
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2015
This publication record appears to combine two very different sets of topics: preclinical cancer pharmacology (a MEK inhibitor drug, AZD6244, used in tumor models) and clinical obstetric medicine (pregnancy management in conditions like hypertension, COVID-19, kidney disease, and inflammatory disease). Because the underlying data mixes these unrelated areas, it is unclear which reflects the researcher's actual focus, but the more recent and repeated items concern obstetric medicine, particularly pregnancy complications and safe prescribing during pregnancy. Prospective students should treat this profile with caution, as the bibliographic record may reflect data-attribution issues rather than a single coherent research program.
Publication output has been low and variable over the last decade, with a notable spike in 2023 followed by a drop, suggesting inconsistent rather than steadily growing or declining activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Figures 1-2 from AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action <i>in vivo</i>, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
2023
- Supplementary Figures 1-2 from AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action <i>in vivo</i>, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
2023
- Data from AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action <i>in vivo</i>, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
2023
- Data from AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action <i>in vivo</i>, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
2023
- Prescribing for pregnancy: inflammatory rheumatic disease
Drug and Therapeutics Bulletin · 2023
- WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic
Trials · 2022
- P41 Inflammatory bowel disease in pregnancy: benefits of multiprofessional working
Poster presentations · 2022
- Case series of COVID-19 infection in pregnancy complicated by ketoacidosis and symptomatic breathlessness
Obstetric Medicine · 2021
- Substance misuse in pregnancy
Obstetrics Gynaecology & Reproductive Medicine · 2020
- Business Assets - Real or Personal
2019
- Medical defence organisations and quality improvement in maternity care
BJOG An International Journal of Obstetrics & Gynaecology · 2019
- Pregnancy in women known to be living with a single kidney
Obstetric Medicine · 2018
- 215. Squamous cell carcinoma of the tongue in pregnancy – An emerging management dilemma
Pregnancy Hypertension · 2018
- Obstetric Medicine×2
- Clinical Breast Cancer×1
- Obstetrics Gynaecology & Reproductive Medicine×1
- Trials×1
- International Journal of Critical Illness and Injury Science×1
- Min Xiao
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kari Kendra
Medicine · The Ohio State University
- Andrea R. Masters
Medicine · Indiana University
- Christin E. Burd
Medicine · The Ohio State University
- Chunying Li
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile